Due to health issues, this site is no longer maintained and will be shut down shortly.

AMRN Amarin Corp PLC ADRs

Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The Company is engaged in commercialization and development of therapeutics to improve cardiovascular health. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$1.54  +0.01 (0.33%)
As of 03/27/2023 11:13:25 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  02/05/2001
Outstanding shares:  98,801,982
Average volume:  5,758,596
Market cap:   $150,179,013
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2301938
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy